Wellington Management Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $75.7M | Buy |
725,044
+21,765
| +3% | +$2.27M | 0.01% | 597 |
|
2025
Q1 | $82M | Buy |
703,279
+30,122
| +4% | +$3.51M | 0.02% | 558 |
|
2024
Q4 | $57M | Sell |
673,157
-69,588
| -9% | -$5.89M | 0.01% | 674 |
|
2024
Q3 | $66.8M | Buy |
742,745
+8,125
| +1% | +$730K | 0.01% | 637 |
|
2024
Q2 | $59.1M | Buy |
734,620
+57,974
| +9% | +$4.67M | 0.01% | 661 |
|
2024
Q1 | $54M | Buy |
676,646
+436,827
| +182% | +$34.9M | 0.01% | 689 |
|
2023
Q4 | $19.1M | Buy |
239,819
+2,265
| +1% | +$180K | ﹤0.01% | 951 |
|
2023
Q3 | $16.6M | Buy |
237,554
+37,843
| +19% | +$2.64M | ﹤0.01% | 974 |
|
2023
Q2 | $14.4M | Buy |
+199,711
| New | +$14.4M | ﹤0.01% | 1022 |
|